{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T11:37:35Z","timestamp":1790681855912,"version":"4.1.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"37","license":[{"start":{"date-parts":[[2012,10,8]],"date-time":"2012-10-08T00:00:00Z","timestamp":1349654400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2012,10,8]],"date-time":"2012-10-08T00:00:00Z","timestamp":1349654400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2013,9,12]]},"DOI":"10.1038\/onc.2012.444","type":"journal-article","created":{"date-parts":[[2012,10,8]],"date-time":"2012-10-08T12:43:35Z","timestamp":1349700215000},"page":"4436-4447","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":110,"title":["Breast tumor-associated osteoblast-derived CXCL5 increases cancer progression by ERK\/MSK1\/Elk-1\/Snail signaling pathway"],"prefix":"10.1038","volume":"32","author":[{"given":"Y-L","family":"Hsu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M-F","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P-L","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y-F","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E-M","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,10,8]]},"reference":[{"key":"BFonc2012444_CR1","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1038\/nrclinonc.2010.134","volume":"7","author":"T Onishi","year":"2010","unstructured":"Onishi T, Hayashi N, Theriault RL, Hortobagyi GN, Ueno NT . Future directions of bone-targeted therapy for metastatic breast cancer. Nat Rev Clin Oncol 2010; 7: 641\u2013651.","journal-title":"Nat Rev Clin Oncol"},{"key":"BFonc2012444_CR2","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.ctrv.2010.04.003","volume":"36","author":"RE Coleman","year":"2010","unstructured":"Coleman RE, Lipton A, Roodman GD, Guise TA, Boyce BF, Brufsky AM et al. Metastasis and bone loss: advancing treatment and prevention. Cancer Treat Rev 2010; 36: 615\u2013620.","journal-title":"Cancer Treat Rev"},{"key":"BFonc2012444_CR3","doi-asserted-by":"publisher","first-page":"42\u2009575","DOI":"10.1074\/jbc.M111.294595","volume":"49","author":"Y Chen","year":"2011","unstructured":"Chen Y, Shi HY, Stock SR, Stern PH, Zhang M . Regulation of breast cancer-induced bone lesions by \u03b2-catenin protein signaling. J Biol Chem 2011; 49: 42\u2009575\u201342584.","journal-title":"J Biol Chem"},{"key":"BFonc2012444_CR4","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1038\/nm0803-999b","volume":"9","author":"LJ Van't Veer","year":"2003","unstructured":"Van't Veer LJ, Weigelt B . Road map to metastasis. Nat Med 2003; 9: 999\u20131000.","journal-title":"Nat Med"},{"key":"BFonc2012444_CR5","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","volume":"100","author":"D Hanahan","year":"2000","unstructured":"Hanahan D, Weinberg RA . The hallmarks of cancer. Cell 2000; 100: 57\u201370.","journal-title":"Cell"},{"key":"BFonc2012444_CR6","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1002\/path.2859","volume":"224","author":"HF Yuen","year":"2011","unstructured":"Yuen HF, Chan YK, Grills C, McCrudden CM, Gunasekharan V, Shi Z et al. Polyomavirus enhancer activator 3 protein promotes breast cancer metastatic progression through Snail-induced epithelial-mesenchymal transition. J Pathol 2011; 224: 78\u201389.","journal-title":"J Pathol"},{"key":"BFonc2012444_CR7","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.cell.2009.11.007","volume":"139","author":"JP Thiery","year":"2009","unstructured":"Thiery JP, Acloque H, Huang RY, Nieto MA . Epithelial-mesenchymal transitions in development and disease. Cell 2009; 139: 871\u2013890.","journal-title":"Cell"},{"key":"BFonc2012444_CR8","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/j.devcel.2008.05.009","volume":"14","author":"J Yang","year":"2008","unstructured":"Yang J, Weinberg RA . Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev Cell 2008; 14: 818\u2013829.","journal-title":"Dev Cell"},{"key":"BFonc2012444_CR9","doi-asserted-by":"publisher","first-page":"15\u2009449","DOI":"10.1073\/pnas.1004900107","volume":"107","author":"JH Taube","year":"2010","unstructured":"Taube JH, Herschkowitz JI, Komurov K, Zhou AY, Gupta S, Yang J et al. Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes. Proc Natl Acad Sci USA 2010; 107: 15\u2009449\u201315454.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2012444_CR10","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.1016\/j.yexcr.2007.04.001","volume":"313","author":"M Jord\u00e0","year":"2007","unstructured":"Jord\u00e0 M, Vinyals A, Marazuela A, Cubillo E, Olmeda D, Valero E et al. Id-1 is induced in MDCK epithelial cells by activated Erk\/MAPK pathway in response to expression of the Snail and E47 transcription factors. Exp Cell Res 2007; 313: 2389\u20132403.","journal-title":"Exp Cell Res"},{"key":"BFonc2012444_CR11","first-page":"1","volume":"83","author":"KL Dunn","year":"2005","unstructured":"Dunn KL, Espino PS, Drobic B, He S, Davie JR . The Ras-MAPK signal transduction pathway, cancer and chromatin remodeling. Biochem. Cell Biol 2005; 83: 1\u201314.","journal-title":"Cell Biol"},{"key":"BFonc2012444_CR12","doi-asserted-by":"publisher","first-page":"4610","DOI":"10.1158\/0008-5472.CAN-05-4251","volume":"66","author":"PS Espino","year":"2006","unstructured":"Espino PS, Li L, He S, Yu J, Davie JR . Chromatin modification of the trefoil factor 1 gene in human breast cancer cells by the Ras\/mitogen-activated protein kinase pathway. Cancer Res 2006; 66: 4610\u20134616.","journal-title":"Cancer Res"},{"key":"BFonc2012444_CR13","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.4049\/jimmunol.182.3.1270","volume":"182","author":"G Pacheco-Rodriguez","year":"2009","unstructured":"Pacheco-Rodriguez G, Kumaki F, Steagall WK, Zhang Y, Ikeda Y, Lin JP et al. Chemokine-enhanced chemotaxis of lymphangioleiomyomatosis cells with mutations in the tumor suppressor TSC2 gene. J Immunol 2009; 182: 1270\u20131277.","journal-title":"J Immunol"},{"key":"BFonc2012444_CR14","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1677\/erc.1.01301","volume":"14","author":"I Bi\u00e8che","year":"2007","unstructured":"Bi\u00e8che I, Chavey C, Andrieu C, Busson M, Vacher S, Le Corre L et al. CXC chemokines located in the 4q21 region are up-regulated in breast cancer. Endocr Relat Cancer 2007; 14: 1039\u20131052.","journal-title":"Endocr Relat Cancer"},{"key":"BFonc2012444_CR15","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.4049\/jimmunol.1002940","volume":"186","author":"PL Kuo","year":"2011","unstructured":"Kuo PL, Hung JY, Huang SK, Chou SH, Cheng DE, Jong YJ et al. Lung cancer-derived galectin-1 mediates dendritic cell anergy through inhibitor of DNA binding 3\/IL-10 signaling pathway. J Immunol 2011; 186: 1521\u20131530.","journal-title":"J Immunol"},{"key":"BFonc2012444_CR16","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.cytogfr.2008.11.005","volume":"20","author":"S Georges","year":"2009","unstructured":"Georges S, Ruiz Velasco C, Trichet V, Fortun Y, Heymann D, Padrines M . Proteases and bone remodelling. Cytokine Growth Factor Rev 2009; 20: 29\u201341.","journal-title":"Cytokine Growth Factor Rev"},{"key":"BFonc2012444_CR17","doi-asserted-by":"publisher","first-page":"37\u2009335","DOI":"10.1074\/jbc.M111.256156","volume":"286","author":"YL Hsu","year":"2011","unstructured":"Hsu YL, Huang MS, Yang CJ, Hung JY, Wu LY, Kuo PL . Lung tumor-associated osteoblast-derived bone morphogenetic protein-2 increased epithelial-to-mesenchymal transition of cancer by Runx2\/Snail signaling pathway. J Biol Chem 2011; 286: 37\u2009335\u201337346.","journal-title":"J Biol Chem"},{"key":"BFonc2012444_CR18","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1615\/CritRevEukarGeneExpr.v10.i2.50","volume":"10","author":"JM Chirgwin","year":"2000","unstructured":"Chirgwin JM, Guise TA . Molecular mechanisms of tumor-bone interactions in osteolytic metastases. Crit Rev Eukaryot Gene Expr 2000; 10: 159\u2013178.","journal-title":"Crit Rev Eukaryot Gene Expr"},{"key":"BFonc2012444_CR19","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1002\/jcp.22445","volume":"226","author":"PL Kuo","year":"2011","unstructured":"Kuo PL, Chen YH, Chen TC, Shen KH, Hsu YL . CXCL5\/ENA78 increased cell migration and epithelial-to-mesenchymal transition of hormone-independent prostate cancer by early growth response-1\/snail signaling pathway. J Cell Physiol 2011; 226: 1224\u20131231.","journal-title":"J Cell Physiol"},{"key":"BFonc2012444_CR20","doi-asserted-by":"publisher","first-page":"14296","DOI":"10.1523\/JNEUROSCI.2890-11.2011","volume":"31","author":"A Besnard","year":"2011","unstructured":"Besnard A, Bouveyron N, Kappes V, Pascoli V, Pag\u00e8s C, Heck N et al. Alterations of molecular and behavioral responses to cocaine by selective inhibition of Elk-1 phosphorylation. J Neurosci 2011; 31: 14296\u201314307.","journal-title":"J Neurosci"},{"key":"BFonc2012444_CR21","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1056\/NEJMra030831","volume":"350","author":"GD Roodman","year":"2004","unstructured":"Roodman GD . Mechanisms of bone metastasis. N Engl J Med 2004; 350: 1655\u20131664.","journal-title":"N Engl J Med"},{"key":"BFonc2012444_CR22","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/nrm1835","volume":"7","author":"JP Thiery","year":"2006","unstructured":"Thiery JP, Sleeman JP . Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol 2006; 7: 131\u2013142.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"BFonc2012444_CR23","doi-asserted-by":"publisher","first-page":"8319","DOI":"10.1158\/0008-5472.CAN-06-0410","volume":"66","author":"JJ Christiansen","year":"2006","unstructured":"Christiansen JJ, Rajasekaran AK . Reassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis. Cancer Res 2006; 66: 8319\u20138326.","journal-title":"Cancer Res"},{"key":"BFonc2012444_CR24","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.ceb.2003.10.006","volume":"15","author":"JP Thiery","year":"2003","unstructured":"Thiery JP . Epithelial-mesenchymal transitions in development and pathologies. Curr Opin Cell Biol 2003; 15: 740\u2013746.","journal-title":"Curr Opin Cell Biol"},{"key":"BFonc2012444_CR25","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1146\/annurev-cellbio-092910-154036","volume":"27","author":"MA Nieto","year":"2011","unstructured":"Nieto MA . The ins and outs of the epithelial to mesenchymal transition in health and disease. Annu Rev Cell Dev Biol 2011; 27: 347\u2013376.","journal-title":"Annu Rev Cell Dev Biol"},{"key":"BFonc2012444_CR26","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nrc2131","volume":"7","author":"H Peinado","year":"2007","unstructured":"Peinado H, Olmeda D, Cano A . Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nat Rev Cancer 2007; 7: 415\u2013428.","journal-title":"Nat Rev Cancer"},{"key":"BFonc2012444_CR27","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1038\/sj.onc.1209997","volume":"26","author":"D Olmeda","year":"2007","unstructured":"Olmeda D, Jord\u00e1 M, Peinado H, Fabra A, Cano A . Snail silencing effectively suppresses tumour growth and invasiveness. Oncogene 2007; 26: 1862\u20131874.","journal-title":"Oncogene"},{"key":"BFonc2012444_CR28","doi-asserted-by":"publisher","first-page":"3241","DOI":"10.1038\/sj.onc.1205416","volume":"21","author":"MJ Blanco","year":"2002","unstructured":"Blanco MJ, Moreno-Bueno G, Sarrio D, Locascio A, Cano A, Palacios J et al. Correlation of Snail expression with histological grade and lymph node status in breast carcinomas. Oncogene 2002; 21: 3241\u20133246.","journal-title":"Oncogene"},{"key":"BFonc2012444_CR29","doi-asserted-by":"publisher","first-page":"3814","DOI":"10.1038\/sj.onc.1204505","volume":"20","author":"CW Cheng","year":"2011","unstructured":"Cheng CW, Wu PE, Yu JC, Huang CS, Yue CT, Wu CW et al. Mechanisms of inactivation of E-cadherin in breast carcinoma: modification of the two-hit hypothesis of tumor suppressor gene. Oncogene 2011; 20: 3814\u20133823.","journal-title":"Oncogene"},{"key":"BFonc2012444_CR30","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.ccr.2005.07.009","volume":"8","author":"SE Moody","year":"2005","unstructured":"Moody SE, Perez D, Pan TC, Sarkisian CJ, Portocarrero CP, Sterner CJ et al. The transcriptional repressor Snail promotes mammary tumor recurrence. Cancer Cell 2005; 8: 197\u2013209.","journal-title":"Cancer Cell"},{"key":"BFonc2012444_CR31","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/35000025","volume":"2","author":"A Cano","year":"2000","unstructured":"Cano A, P\u00e9rez-Moreno MA, Rodrigo I, Locascio A, Blanco MJ, del Barrio MG et al. The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol 2000; 2: 76\u201383.","journal-title":"Nat Cell Biol"},{"key":"BFonc2012444_CR32","doi-asserted-by":"publisher","first-page":"9228","DOI":"10.1158\/0008-5472.CAN-09-1950","volume":"69","author":"H Chen","year":"2009","unstructured":"Chen H, Zhu G, Li Y, Padia RN, Dong Z, Pan ZK et al. Extracellular signal-regulated kinase signaling pathway regulates breast cancer cell migration by maintaining slug expression. Cancer Res 2009; 69: 9228\u20139235.","journal-title":"Cancer Res"},{"key":"BFonc2012444_CR33","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1002\/1097-0215(20000720)89:4<384::AID-IJC11>3.0.CO;2-R","volume":"89","author":"H Mueller","year":"2000","unstructured":"Mueller H, Flury N, Eppenberger-Castori S, Kueng W, David F, Eppenberger U . Potential prognostic value of mitogen-activated protein kinase activity for disease-free survival of primary breast cancer patients. Int J Cancer 2000; 89: 384\u2013388.","journal-title":"Int J Cancer"},{"key":"BFonc2012444_CR34","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1172\/JCI119309","volume":"99","author":"VS Sivaraman","year":"1997","unstructured":"Sivaraman VS, Wang H, Nuovo GJ, Malbon CC . Hyperexpression of mitogen-activated protein kinase in human breast cancer. J Clin Invest 1997; 99: 1478\u20131483.","journal-title":"J Clin Invest"},{"key":"BFonc2012444_CR35","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1016\/j.bbamcr.2006.10.001","volume":"1773","author":"JA McCubrey","year":"2007","unstructured":"McCubrey JA, Steelman LS, Chappell WH, Abrams SL, Wong EW, Chang F et al. Roles of the Raf\/MEK\/ERK pathway in cell growth, malignant transformation and drug resistance. Biochim Biophys Acta 2007; 1773: 1263\u20131284.","journal-title":"Biochim Biophys Acta"},{"key":"BFonc2012444_CR36","doi-asserted-by":"publisher","first-page":"2594","DOI":"10.1093\/nar\/gkn099","volume":"36","author":"HM Zhang","year":"2008","unstructured":"Zhang HM, Li L, Papadopoulou N, Hodgson G, Evans E, Galbraith M et al. Mitogen-induced recruitment of ERK and MSK to SRE promoter complexes by ternary complex factor Elk-1. Nucleic Acids Res 2008; 36: 2594\u20132607.","journal-title":"Nucleic Acids Res"},{"key":"BFonc2012444_CR37","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1128\/MCB.00756-10","volume":"31","author":"B Cassinat","year":"2011","unstructured":"Cassinat B, Zassadowski F, Ferry C, Llopis L, Bruck N, Lainey E et al. New role for granulocyte colony-stimulating factor-induced extracellular signal-regulated kinase 1\/2 in histone modification and retinoic acid receptor \u03b1 recruitment to gene promoters: relevance to acute promyelocytic leukemia cell differentiation. Mol Cell Biol 2011; 31: 1409\u20131418.","journal-title":"Mol Cell Biol"},{"key":"BFonc2012444_CR38","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.molcel.2006.10.011","volume":"24","author":"GP Vicent","year":"2006","unstructured":"Vicent GP, Ballar\u00e9 C, Nacht AS, Clausell J, Subtil-Rodr\u00edguez A, Quiles I et al. Induction of progesterone target genes requires activation of Erk and Msk kinases and phosphorylation of histone H3. Mol Cell 2006; 24: 367\u2013381.","journal-title":"Mol Cell"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/onc2012444.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2012444","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2012444.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T18:15:40Z","timestamp":1647886540000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/onc2012444"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10,8]]},"references-count":38,"journal-issue":{"issue":"37","published-print":{"date-parts":[[2013,9,12]]}},"alternative-id":["BFonc2012444"],"URL":"https:\/\/doi.org\/10.1038\/onc.2012.444","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,10,8]]},"assertion":[{"value":"22 March 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2012","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2012","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2012","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}